Biotech CEO Sisterhood: Trevi Therapeutics' Co-Founder & CEO Jennifer Good on effective communication and capital efficiency, and a unique internship program in life sciences

Interviewed by Sisterhood editorial board member Erika Smith, Jennifer Good describes the factors that have led to Trevi's success in an otherwise difficult biotech market. She highlights the importance of speaking clearly and honestly with investors and the company's board. Plus, Erika and Jennifer reflect on Life-Science SPRINTS, an internship program they stood up in the New Haven, Connecticut area.